Cargando…
Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
PURPOSE: To evaluate the short-term effects of a single subconjunctival injection of triamcinolone acetonide as an adjunct to subconjunctival bevacizumab for prevention of corneal neovascularization in rats. METHODS: Chemical cauterization was performed in the central cornea of the right eye in 48 m...
Autores principales: | Mehrjardi, Hadi Z., Ghaffari, Reza, Mahbod, Mirgholamreza, Hashemi, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181197/ https://www.ncbi.nlm.nih.gov/pubmed/25279116 |
Ejemplares similares
-
Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008) -
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Monolith/Hydrogel composites as triamcinolone acetonide carriers for curing corneal neovascularization in mice by inhibiting the fibrinolytic system
por: Huang, Cixin, et al.
Publicado: (2021) -
Triamcinolone acetonide acetate
por: Lu, Xiao, et al.
Publicado: (2011) -
Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide
por: McAllister, Ian L., et al.
Publicado: (2023)